SCHEMBL6985344

SCHEMBL6985344

Nc1nc(N)nc(-c2cnc3ccccc3c2)n1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.57
ADORA3 P0DMS8 1/20 0.57
ADORA2A P29274 1/20 0.57
ADORA2B P29275 1/20 0.57
ADORA1 P30542 1/20 0.57
PDGFRB P09619 3/20 0.54
PDGFRA P16234 3/20 0.54
CYP2A6 P11509 1/20 0.51
BIRC5 O15392 1/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA9 Q16790 1/20 0.50
PIK3CD O00329 1/20 0.49
PIK3CA P42336 1/20 0.49
MAP4K4 O95819 1/20 0.48
CSNK1G2 P78368 1/20 0.48
CLK4 Q9HAZ1 1/20 0.48
MKNK2 Q9HBH9 1/20 0.48
MAP4K5 Q9Y4K4 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29818168 0.81 PDGFRB (0.62) PDGFRBPDGFRACYP2A6BIRC5CA12
SCHEMBL2772360 0.80 PDGFRB (0.77) POLBPDGFRBPDGFRACYP2A6BIRC5
SCHEMBL32667946 0.80 PDGFRB (0.77) POLBPDGFRBPDGFRACYP2A6BIRC5
SCHEMBL17944740 0.80 PDGFRB (0.61) PDGFRBPDGFRACYP2A6BIRC5CA12
SCHEMBL24412080 0.79 PDGFRB (0.65) POLBPDGFRBPDGFRACYP2A6BIRC5
SCHEMBL10498512 0.79 PDGFRB (0.54) PDGFRBPDGFRACYP2A6BIRC5CA12
SCHEMBL10051400 0.79 PDGFRB (0.54) POLBPDGFRBPDGFRACYP2A6BIRC5
SCHEMBL10051316 0.77 PDGFRB (0.57) PDGFRBPDGFRACYP2A6BIRC5CA12
SCHEMBL19943005 0.76 PDGFRB (0.66) PDGFRBPDGFRACYP2A6BIRC5CA12
SCHEMBL12580362 0.76 PDGFRB (0.66) PDGFRBPDGFRACYP2A6BIRC5CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6150362-A ADMINISTERING 1,3,5-SUBSTITUTED TRIAZINE COMPOUNDS TO THE PATIENT SUFFERING FROM ANGIOGENIC DISEASES ABBVIE INC. 2000-11-21 US claimed
EP-1037886-B1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LAB (US) 2003-05-02 EP disclosed
US-6288228-B1 DIAMINOTRIAZINE DERIVATIVES ABBOTT LABORATORIES 2001-09-11 US disclosed
US-6150362-A ADMINISTERING 1,3,5-SUBSTITUTED TRIAZINE COMPOUNDS TO THE PATIENT SUFFERING FROM ANGIOGENIC DISEASES ABBVIE INC. 2000-11-21 US disclosed